SP-MHCI-1292-2

Proton-coupled zinc antiporter SLC30A2 153-161, VVTGVLVYL

US$169.00

In stock

Description

About Proton-coupled zinc antiporter SLC30A2 153-161, VVTGVLVYL

The Human Proton-coupled zinc antiporter SLC30A2 Peptide (IEDB: 170038) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Proton-coupled zinc antiporter SLC30A2 Peptide, H-VVTGVLVYL-OH (Uniprot: Q9BRI3 aa: 153-161) from JPT is produced under strict quality control and quality management.

Proton-coupled zinc antiporter SLC30A2 153-161, VVTGVLVYL - Specifications

  • Peptide sequence: H-VVTGVLVYL-OH
  • Amount: 1 mg
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Diabetes
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for Proton-coupled zinc antiporter SLC30A2 153-161, VVTGVLVYL

References:
Read References with JPT’s Antigen Peptides

Proton-coupled zinc antiporter SLC30A2 153-161, VVTGVLVYL has been described in:
ZnT8 is a major CD8+ T cell-recognized autoantigen in pediatric type 1 diabetes., Diabetes, 2012 (PMID: 22586580.0)
Zinc transporter (ZnT)8(186-194) is an immunodominant CD8+ T cell epitope in HLA-A2+ type 1 diabetic patients., Diabetologia, 2012 (PMID: 22526607.0)
Characterization of immune response to novel HLA-A2-restricted epitopes from zinc transporter 8 in type 1 diabetes., Vaccine, 2016 (PMID: 26541133.0)

Documentation

Documentation for Proton-coupled zinc antiporter SLC30A2 153-161, VVTGVLVYL

Properties

Properties of Proton-coupled zinc antiporter SLC30A2 153-161, VVTGVLVYL

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Diabetes
Layout: Freeze-dried in glass vial
Organism: Human
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No

Further Information to Proton-coupled zinc antiporter SLC30A2 153-161, VVTGVLVYL

Information Values
Sequence: H-VVTGVLVYL-OH
Specifications: 9mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote